Table 1 Comparison of Toxoplasma gondii-seropositive and -seronegative groups before propensity score matching

N

14,181

10,350

3831

All-cause mortality, n (%)

5082 (35.8)

3166 (30.6)

1916 (50.0)

 < 0.001

Follow-up time (years)

22.5 [16.3, 24.5]

22.8 [19.8, 24.7]

21.7 [10.8, 24.1]

 < 0.001

Race, n (%)

 < 0.001

 - Non-Hispanic white

5827 (41.1)

4116 (39.8)

1711 (44.7)

 - Non-Hispanic black

3882 (27.4)

2922 (28.2)

960 (25.1)

 - Mexican–American

3912 (27.6)

2994 (28.9)

918 (24.0)

 - Other

560 (3.9)

318 (3.1)

242 (6.3)

Male, n (%)

6672 (47.0)

4760 (46.0)

1912 (49.9)

 < 0.001

Age (years)

46.3 ± 19.5

43.6 ± 18.7

53.7 ± 19.7

 < 0.001

Low family income, n (%)

3068 (21.6)

2204 (21.3)

864 (22.6)

0.111

Low educational level, n (%)

5637 (39.8)

3755 (36.3)

1882 (49.1)

 < 0.001

Type 2 diabetes, n (%)

2128 (15.0)

1353 (13.1)

775 (20.2)

 < 0.001

Hypertension, n (%)

5859 (41.3)

3935 (38.0)

1924 (50.2)

 < 0.001

BMI (kg/m²)

27.1 ± 5.7

26.9 ± 5.8

27.4 ± 5.6

 < 0.001

Waist (cm)

92.9 ± 14.6

92.2 ± 14.7

94.9 ± 14.1

 < 0.001

White blood cell (× 10⁹/l)

7.2 ± 2.3

7.2 ± 2.3

7.2 ± 2.5

0.567

Hemoglobin (g/l)

139.4 ± 15.2

139.4 ± 15.2

139.3 ± 15.2

0.854

Platelets (× 10⁹/l)

274.1 ± 71.1

275.9 ± 70.7

269.2 ± 71.9

 < 0.001

CRP (mg/dl)

0.5 ± 0.8

0.5 ± 0.7

0.5 ± 0.9

0.005

FBG (mmol/l)

5.5 ± 2.1

5.5 ± 2

5.8 ± 2.3

 < 0.001

HbA1c (%)

5.5 ± 1.1

5.5 ± 1.1

5.7 ± 1.2

 < 0.001

Cholesterol (mmol/l)

5.3 ± 1.2

5.2 ± 1.2

5.4 ± 1.2

 < 0.001

Triglyceride (mmol/l)

1.6 ± 1.3

1.6 ± 1.3

1.7 ± 1.4

 < 0.001

AST (U/l)

19 [16, 24]

19 [16, 24]

19 [17, 24]

 < 0.001

ALT (U/l)

14 [10, 20]

14 [10, 20]

14 [10, 19]

0.046

Albumin (g/l)

41.4 ± 3.8

41.5 ± 3.8

41.1 ± 3.7

 < 0.001

Creatinine (μmol/l)

88.4 [79.6, 106.1]

88.4 [79.6, 106.1]

97.2 [79.6, 106.1]

 < 0.001

BUN (mmol/l)

5.1 ± 2.0

4.9 ± 1.9

5.5 ± 2.3

 < 0.001

Uric acid (μmol/l)

318.1 ± 88.1

314.3 ± 86.8

328.5 ± 90.7

 < 0.001